BioCentury
ARTICLE | Company News

Cristal Therapeutics, PX Biosolutions deal

August 24, 2015 7:00 AM UTC

The companies will combine Cristal’s CriVac technology and PX’s DCtag vaccine formulation to develop cancer vaccines. The CriVac technology uses polymeric nanoparticles to facilitate optimal antigen p...